Back to UBS Group AG UBS Group AG

AKBAAKBA
30 quarters

Position history for UBS Group AGUBS Group AG's holdings in AKEBIA THERAPEUTICS INC

Yes. Ubs holds 1,374,950 shares of AKBA (Akebia Therapeutics), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 605,479 shares (+78.7%) from Q1 2026. Ubs has held AKBA in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$1.6M

Current Shares

1.4M

Total Value Change

+$356,442

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+78.7%
$1.6M0.0%$1.14
39
2026-Q1
Decreased
769,471
-11.7%
$1.1M0.0%$1.22
0
2025-Q4
Decreased
871,534
-76.1%
$1.4M0.0%$1.59
0
2025-Q3
Increased
3.6M
+470.2%
$10M0.0%$2.71
45
2025-Q2
Increased
639,462
+7.9%
$2.3M0.0%$3.65
28
2025-Q1
Increased
592,410
+68.7%
$1.1M0.0%$1.91
37
2024-Q4
Increased
351,091
+128.5%
$667,0730.0%$1.85
40
2024-Q3
Increased
153,662
+7.6%
$202,8330.0%$1.33
17
2024-Q2
Increased
142,828
+43.8%
$145,6840.0%$1.02
20
2024-Q1
Decreased
99,338
-36.7%
$181,7890.0%$1.83
0
2023-Q4
Increased
157,030
+128.5%
$194,7170.0%$1.24
37
2023-Q3
Decreased
68,728
-3.9%
$78,3490.0%$1.14
0
2023-Q2
Decreased
71,488
-18.7%
$65,4120.0%$0.93
0
2023-Q1
Increased
87,975
+49.7%
$49,2660.0%$0.56
19
2022-Q4
Decreased
58,755
-55.5%
$34,0780.0%$0.58
0
2022-Q3
Increased
131,961
+1.0%
$41,0000.0%$0.30
14
2022-Q2
Decreased
130,652
-83.0%
$46,0000.0%$0.38
0
2022-Q1
Increased
769,438
+59.4%
$553,0000.0%$0.83
35
2021-Q4
Decreased
482,650
-8.7%
$1.1M0.0%$2.29
0
2021-Q3
Increased
528,845
+282.2%
$1.5M0.0%$2.86
41
2021-Q2
Decreased
138,356
-57.9%
$524,0000.0%$3.86
0
2021-Q1
Increased
328,281
+140.9%
$1.1M0.0%$3.10
41
2020-Q4
Decreased
136,247
-19.9%
$381,0000.0%$2.99
0
2020-Q3
Increased
170,063
+30.5%
$427,0000.0%$2.39
30
2020-Q2
Decreased
130,325
-17.3%
$1.8M0.0%$12.70
0
2020-Q1
Decreased
157,487
-29.2%
$1.2M0.0%$7.96
0
2019-Q4
Decreased
222,576
-29.7%
$1.4M0.0%$6.58
0
2019-Q3
Increased
316,589
+24.2%
$1.2M0.0%$4.12
31
2019-Q2
Increased
254,909
+72.4%
$1.2M0.0%$4.84
38
2019-Q1
First report
147,834
-
$1.2M0.0%$8.19
0

Other major holders of AKBA: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used